Investors

A proven track record of value creation

Our robust business model provides significant opportunities to drive growth and deliver value for investors.

Together we’re building a leading global pharmaceutical business 

By putting better health within reach of patients every day through investment, innovation and diversification, we’re enhancing our portfolio responsibly and creating strong shareholder returns.

Explore our strategy

Latest stories

Decorative image.
Featured

Strong 2024 performance and a positive outlook for 2025

Press Release, Financial Results 26 February 2025